These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Comparison of two long-acting theophylline preparations in daily evening administration]. Holzer R Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685 [TBL] [Abstract][Full Text] [Related]
4. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma]. Liebke C; Niggemann B; Wahn U Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442 [TBL] [Abstract][Full Text] [Related]
6. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma. Chhabra SK Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732 [TBL] [Abstract][Full Text] [Related]
13. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients. Adachi M; Aizawa H; Ishihara K; Ohta K; Sano Y; Taniguchi H; Nakashima M Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance]. Ukena D; Koper I; Braun H; Leutz M; Schlimmer P; Sybrecht GW Pneumologie; 1997 Mar; 51(3):317-23. PubMed ID: 9173422 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage]. Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma]. Ukena D; Harnest U; Sakalauskas R; Magyar P; Vetter N; Steffen H; Leichtl S; Rathgeb F; Keller A; Steinijans VW Pneumologie; 1998 Jul; 52(7):377-84. PubMed ID: 9738388 [TBL] [Abstract][Full Text] [Related]
18. [Effects of once-daily low-dose administration of sustained-release theophylline on airway inflammation and airway hyperresponsiveness in patients with asthma]. Terao I Arerugi; 2002 Apr; 51(4):364-70. PubMed ID: 12014027 [TBL] [Abstract][Full Text] [Related]
19. [Euphylong in patients with chronic obstructive airway diseases]. Kublik A; von Wichert P Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups]. Berdel D; von Berg A; Reinhardt D; Heimann G; Steinijans VW; Sauter R Pneumologie; 1991 Nov; 45 Suppl 4():863-6. PubMed ID: 1812481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]